Meet top PFS experts, network with 100+ pharma and biotech industry leaders next week in Boston Read more
Gilead Launches HepConnect Initiative to Reduce Hepatitis C Infections in Greater Appalachia Read more
AstraZeneca and Daiichi Sankyo enter collaboration for novel HER2-targeting antibody-drug conjugate Read more
Barc Lab and OWL Metabolomics Announce Strategic Partnership on Deploying Metabolomic Technology in Clinical Trials Read more
Novartis receives FDA approval for Mayzent (siponimod), the first oral drug to treat secondary progressive MS with active disease Read more
OcellO announces two year agreement with Merus to provide in vitro research services for MCLA-158 and other undisclosed Biclonics programs Read more
Velicept Therapeutics Announces Positive Top-Line Phase 2b Results for Solabegron in the Treatment of Overactive Bladder (OAB) Read more
StrideBio and Takeda Sign Collaboration and License Agreement to Advance Novel Gene Therapies for Neurological Diseases Read more